Skip to NavigationSkip to content

News

AstraZeneca has shed light on the possible efficacy of its Bruton’s tyrosine kinase (BTK) inhibitor Calquence (acalabrutinib) in the treatment of...
Nearly two-thirds of people in Britain have been denied care for common life-threatening conditions by the NHS, due to their resources being focused...
The US government will run out of their current supply of Gilead’s remdsivir by the end of the month, the only drug known to properly treat the...
Oxford Biomedica has forged a five-year partnership with the Vaccines Manufacturing and Innovation Centre (VMIC) to work together to provide...
The pharmaceutical industry has warned the UK government that certain stockpiles of medicine have been used up due to the pandemic, according to the...
Australia could be set to follow the decisions of other nations around the world in officially licensing Gilead’s antiviral therapy remdesivir in the...
The NHS COVID-19 test-and-trace system will not be fully operational until September or October, leaked emails from personnel involved with its...
The Lancet has retracted a paper that claimed to show that people who took hydroxychloroquine to treat COVID-19 had a higher risk of developing heart...
AstraZeneca has revealed it has stepped up its own efforts to provide access to the candidate it is working on with the University of Oxford, sealing...
This week has seen the development of coronavirus vaccines move forward, as the Trump administration has selected the finalists for the COVID-19...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches